NCT06404151

Brief Summary

The primary aim of this study is to compare the effectiveness of ORI and rcSO2 in predicting hypoxia early in obese patients who are sensitive to hypoxia. Our secondary aim is; To determine whether there is a correlation between the changing trend of ORI and rcSO2 in obese patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 8, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

1.1 years

First QC Date

February 28, 2024

Last Update Submit

May 11, 2024

Conditions

Keywords

Oxygen reserve index,PreoxygenationCerebral Oxygen Saturation

Outcome Measures

Primary Outcomes (1)

  • Comparison of Oxygen Reserve Index and Regional Cerebral Oxygen Saturation Indetermining Hypoxia in Obese Patients

    The primary aim of this study is to compare the effectiveness of ORI and rcSO2 in predicting hypoxia early in obese patients (BMI 30-40 kg/m\^2) (weight and height will be combined to report BMI in kg/m\^2)

    after intubation time until spO2 reaches to 97% and 94% and ori reaches to the plato.Expected to take approximately five minutes

Secondary Outcomes (1)

  • Comparison of Oxygen Reserve Index and Regional Cerebral Oxygen Saturation Indetermining Hypoxia in Obese Patients

    time until spo2 is 94% and 97% and ori reaches to the plato.Expected to take approximately five minutes

Study Arms (1)

Obese Patients

60 patients with ASA I-III, of both genders, between 18-75 years of age, with a BMI of 40\>30 kg m2 and intubated under general anesthesia

Device: monitoring

Interventions

rc02, ORI , spO2

Obese Patients

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

60 patients with ASA I-III, of both genders, between 18-75 years of age, with a BMI of 40\>30 kg m2 and intubated under general anesthesia

You may qualify if:

  • ASA I-III patients
  • The ages of 18-75
  • Obese BMI (40\>BMI\>30 kgm\^2)
  • Undergoing intubated elective surgery

You may not qualify if:

  • Patients with significant cardiopulmonary comorbidities
  • BMI\>40 kgm\^2 and BMI\<30 kg m\^2
  • ASA\>3
  • Patients under 18 years and over 75 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Science, Kartal Dr Lütfi Kırdar Training and Research Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

Related Publications (2)

  • Scheeren TWL, Belda FJ, Perel A. The oxygen reserve index (ORI): a new tool to monitor oxygen therapy. J Clin Monit Comput. 2018 Jun;32(3):379-389. doi: 10.1007/s10877-017-0049-4. Epub 2017 Aug 8.

  • Fleming NW, Singh A, Lee L, Applegate RL 2nd. Oxygen Reserve Index: Utility as an Early Warning for Desaturation in High-Risk Surgical Patients. Anesth Analg. 2021 Mar 1;132(3):770-776. doi: 10.1213/ANE.0000000000005109.

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gülten A Arslan, Assos Prof

    Dr Lütfi Kırdar City Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gülten A Arslan, Assos Prof

CONTACT

Banu Eler Cevik, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assos prof

Study Record Dates

First Submitted

February 28, 2024

First Posted

May 8, 2024

Study Start

July 1, 2023

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

May 14, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

I will share the parameters and results of the study

Locations